Analysis of the expression and roles of receptor-type tyrosine kinase in keloid tissue
受体型酪氨酸激酶在瘢痕疙瘩组织中的表达及作用分析
基本信息
- 批准号:10671682
- 负责人:
- 金额:$ 1.79万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Keloid is a dermal fibroproliferative tissue of unknown etiology. Protein tyrosine kinases (PTKs) play an important role in the regulation of cell growth and differentiation. Activation of PTK cascade in keloid fibroblasts is thought to be closely linked to abnormal cell proliferation and migration.In order to examine the expression of receptor-type PTK in normal and keloid fibroblasts, we used the homology cloning method with a degenerated primer. Although 8 receptor-type PTK genes were expressed in both fibroblasts, insulin-like growth factor-I receptor (IGF-IR) was overexpressed only in keloid fibroblasts. Immunohistochemical analysis confirmed the high expression of IGF-IR.To examine the functional properties of the IGF-I/IGF-IR pathway, we investigated cell proliferation invasion activity and apoptosis of both types of fibroblasts. The mitogenic effect of IGF-I on both fibroblasts was very weak compared with serum stimulation. In contrast, the invasive activity of keloid fibroblasts was markedly increased in the presence of IGF-I, and inhibited by a neutralizing antibody against IGF-IR. Also keloid fibroblasts resisted apoptosis induced by C2-ceramide. Exogenously added IGF-I enhanced the resistance of keloid fibroblasts to ceramide-induced apoptosis. Wortmannin, a phosphatidylinositol 3-kinase (PI3-K) inhibitor suppressed the anti-apoptotic action of IGF-I in keloid fibroblasts.These findings suggest that the involvement of activated IGF-I/IGF-IR signal in the pathogenesis of keloid by enhancing the invasive activity and the resistance to apoptosis of fibroblasts.
瘢痕疙瘩是一种病因不明的皮肤纤维增生性组织。蛋白酪氨酸激酶(PTKs)在调节细胞生长和分化中起着重要作用。瘢痕疙瘩成纤维细胞中PTK级联的激活被认为与异常细胞增殖和迁移密切相关。为了检测受体型PTK在正常和瘢痕疙瘩成纤维细胞中的表达,我们采用了带退化引物的同源克隆方法。尽管8种受体型PTK基因在两种成纤维细胞中均有表达,但胰岛素样生长因子- 1受体(IGF-IR)仅在瘢痕疙瘩成纤维细胞中过表达。免疫组化分析证实IGF-IR高表达。为了研究IGF-I/IGF-IR通路的功能特性,我们研究了两种类型成纤维细胞的细胞增殖、侵袭活性和凋亡。与血清刺激相比,igf - 1对两种成纤维细胞的有丝分裂作用非常弱。相反,瘢痕疙瘩成纤维细胞的侵袭活性在IGF-I的存在下显著增加,并被抗IGF-IR的中和抗体抑制。瘢痕疙瘩成纤维细胞也能抵抗c2 -神经酰胺诱导的细胞凋亡。外源性添加igf - 1增强瘢痕疙瘩成纤维细胞对神经酰胺诱导的细胞凋亡的抗性。磷脂酰肌醇3-激酶(PI3-K)抑制剂Wortmannin抑制瘢痕疙瘩成纤维细胞中IGF-I的抗凋亡作用。这些发现提示,激活的IGF-I/IGF-IR信号通过增强成纤维细胞的侵袭活性和抗凋亡能力参与瘢痕疙瘩的发病过程。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Mutaf, et al.: "An experimental study in rats"Brit J Plast Surg. 53. 393-401 (1998)
M.Mutaf 等人:“大鼠实验研究”Brit J Plast Surg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Yoshimoto, et al.: "Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy"Plast Reconstr Surg. 102. 1605-1610 (1998)
H.Yoshimoto 等人:“先天性半面肥大中成骨细胞的增殖活性增加”Plast Reconstr Surg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
R.Murakami, et al.: "Free groin flap for reconstruction of the tongue and oral floor"J reconstr Microsurg. 14. 49-55 (1998)
R.Murakami 等人:“用于重建舌头和口腔底的游离腹股沟皮瓣”J reconstr Microsurg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Yamashita, et al.: "Editorial: Sporadic multiple endocrine neoplasa type 2A"Intern Med. 38:2. 80 (1999)
S.Yamashita 等人:“社论:散发性多发性内分泌肿瘤 2A 型”Intern Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Yoshimoto, et al.: "Overexpression of insulin-like growth factor-1(IGF-I) receptor and the invasiveness of cultured keloid fibroblasts"Am J Pathol. 154. 883-889 (1999)
H.Yoshimoto 等人:“胰岛素样生长因子-1 (IGF-I) 受体的过度表达和培养的瘢痕疙瘩成纤维细胞的侵袭性”Am J Pathol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMASHITA Shunichi其他文献
YAMASHITA Shunichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMASHITA Shunichi', 18)}}的其他基金
Molecular epidemiological study of thyroid cancers by international collaboration
国际合作的甲状腺癌分子流行病学研究
- 批准号:
16H02774 - 财政年份:2016
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Morphological analysis of mitochondria during mitophagy
线粒体自噬过程中线粒体的形态学分析
- 批准号:
15K18501 - 财政年份:2015
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Elucidation of Prognostic Markers and their Molecular Mechanism for Thyroid Cancer
甲状腺癌预后标志物及其分子机制的阐明
- 批准号:
26293222 - 财政年份:2014
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Provocative epidemiological study on identification of factor of thyroid carcinogenesis
甲状腺癌发生因素鉴定的前瞻性流行病学研究
- 批准号:
26670460 - 财政年份:2014
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular Epidemiological Study on Risk of Radiation-associated Cancer after the Chernobyl Nuclear Power Plant accident
切尔诺贝利核电站事故后辐射相关癌症风险的分子流行病学研究
- 批准号:
25257508 - 财政年份:2013
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Large-scale cohort molecular epidemiological study after the Chernobyl accident
切尔诺贝利事故后大规模队列分子流行病学研究
- 批准号:
22256004 - 财政年份:2010
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Elucidation of molecular mechanism on thyroid carcinogenesis anddevelopmental application of molecular targeting therapy
甲状腺癌发生分子机制阐明及分子靶向治疗的发展应用
- 批准号:
22390189 - 财政年份:2010
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Long-term molecular epidemiological studies on thyroid cancers around Chernobyl
切尔诺贝利周围甲状腺癌的长期分子流行病学研究
- 批准号:
19256003 - 财政年份:2007
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Elucidation of thyroid carcinogenesis and clinical application of molecular targeting therapy
甲状腺癌发生机制的阐明及分子靶向治疗的临床应用
- 批准号:
19390253 - 财政年份:2007
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Epidemiology of Thyroid Diseases around Semiparatinsk, Kazakhstan and Altai region, Russia
哈萨克斯坦塞米帕拉金斯克和俄罗斯阿尔泰地区甲状腺疾病的分子流行病学
- 批准号:
12576020 - 财政年份:2000
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Regulation of cell division by the receptor-type tyrosine kinase
受体型酪氨酸激酶对细胞分裂的调节
- 批准号:
19K07055 - 财政年份:2019
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction of the phosphorylation signal response of receptor-type tyrosine kinase (RTK) inhibitors using miRNA as a biomarker.
使用 miRNA 作为生物标志物预测受体型酪氨酸激酶 (RTK) 抑制剂的磷酸化信号反应。
- 批准号:
15K08083 - 财政年份:2015
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of novel anticancer lead compounds targeting receptor-type tyrosine kinase Met molecule
创建针对受体型酪氨酸激酶 Met 分子的新型抗癌先导化合物
- 批准号:
25460156 - 财政年份:2013
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular pathological analysis of the expression of receptor-type tyrosine kinase in hepatocellular carcinoma
受体型酪氨酸激酶在肝细胞癌中表达的分子病理学分析
- 批准号:
10670211 - 财政年份:1998
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal transduction for cell proliferation, apoptosis and differentiation via receptor-type tyrosine kinase and Shc molecule.
通过受体型酪氨酸激酶和Shc分子进行细胞增殖、凋亡和分化的信号转导。
- 批准号:
10680662 - 财政年份:1998
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement of receptor-type tyrosine kinase gene families in cardiac hypertrophy.
受体型酪氨酸激酶基因家族参与心脏肥大。
- 批准号:
09670729 - 财政年份:1997
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




